MedTrace Logo

Peripheral Artery Disease and Sepsis Outcomes

NCT03372330 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-12-13

No results posted yet for this study

Summary

The peripheral artery disease (PAD) prevalence is high in the elderly, the diabetic patients, and the patients receiving hemodialysis. To date, there is no guideline recommendation on the screening of PAD in patients admitted to the medical intensive care unit (MICU) for sepsis.

We conducted a prospective cohort study focusing on patients admitted to the MICU with the main diagnosis of sepsis. The ankle-brachial indexes are performed within 24 hours after admission. Invasive arterial line monitoring and standard non-invasive measurements are collected. After confirmation of PAD, standard anti-platelet treatments (aspirin and cilostazol) are initiated. The survival before and after the conduction of this trial is compared to historical records. The outcomes including all-cause mortality, stroke, myocardial infarction, minor amputation, major amputation, and prolonged ventilator dependent are to be collected.

Conditions

Interventions

DRUG

Standard care for sepsis and PAD

The standard medications care for the patient with PAD included antiplatelet agents.

DRUG

Standard care for sepsis

The standard care for the patient with sepsis.

Sponsors & Collaborators

  • National Taiwan University Hospital Hsin-Chu Branch

    lead OTHER

Principal Investigators

  • Mu-Yang Hsieh, MD · National Taiwan University Hospital Hsin-Chu Branch

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-11
Primary Completion
2018-09-10
Completion
2019-09-10

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03372330 on ClinicalTrials.gov